Head-to-Head

Aktis Oncology, Inc. Common stock vs. Johnson & Johnson

AKTS

Aktis Oncology, Inc. Common stock

$16.55 -0.45%

VS JNJ

Johnson & Johnson

$287.47 +0.60%

Johnson & Johnson (JNJ) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

AKTSJNJ
Market Cap $927.36 million $687.89 billion

JNJ leads on 1 of 1 size & scale factors.

Dividend

AKTSJNJ
Dividend Yield — 1.86%

AKTS and JNJ split the dividend factors evenly.

Risk & Sentiment

AKTSJNJ
Short Interest 1.61% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: AKTS overview, AKTS financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.